Merck & Co., Inc.
MRK
Below: live stock price for Merck & Co., Inc. (MRK), a 1-year chart, 8 indicators (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volume), and a compare mode. Add to your portfolio, star to your watchlist, or set a price alert in one place.
Merck & Co., Inc. (MRK) trades at 127.5 USD on investpig.
- Prev close
- $127.63
- Volume (24h)
- $1.36B
- Market cap
- $314.90B
- Currency
- USD
Score
50/ 100 · Mixed
- Value—
- Quality—
- Momentum—
- Growth—
- Risk—
- Dividend—
- Liquidity—
Composite of public market data. Informational only — not investment advice.
Trend projection
Where the recent trend points if it continues.
- +5 bars
- 128.7118 +0.95%
- +20 bars
- 130.4027 +2.28%
- +60 bars
- 131.0628 +2.79%
- +120 bars
- 131.0871 +2.81%
Linear-regression continuation — not a prediction, not investment advice. ±1σ ≈ 68% range · ±2σ ≈ 95% range: ±0.0265 USD.
Interpretation
Price sits near the upper third of the recent range, trend is sloping upward.
Descriptive observation — not investment advice.
Reference levels
Fibonacci retracements and extensions across the recent range.
Reference only — not investment advice.
These coordinates describe past-trade clustering, not where to buy or sell. Do your own research before any trade.
- ResistanceFib +161.8% extension170.3131 USD+33.58% from current
- ResistanceFib +100% extension155.58 USD+22.02% from current
- ResistanceFib +61.8% extension146.4731 USD+14.88% from current
- ResistanceFib +27.2% extension138.2245 USD+8.41% from current
- Current127.5 USD
- SupportFib 23.6% retracement126.1138 USD-1.09% from current
- SupportFib 38.2% retracement122.6331 USD-3.82% from current
- SupportFib 50% midpoint119.82 USD-6.02% from current
- SupportFib 61.8% retracement117.0069 USD-8.23% from current
- SupportFib 78.6% retracement113.0018 USD-11.37% from current
- SupportFib −27.2% extension101.4155 USD-20.46% from current
- SupportFib −61.8% extension93.1669 USD-26.93% from current
- SupportFib −100% extension84.06 USD-34.07% from current
Recent news
- Merck (MRK) Wins FDA Approval For First Oral PCSK9 Cholesterol DrugSimply Wall St.20h ago
- What Comes After Merck’s Keytruda? The Race for the Next Standard Cancer Treatment.Barrons.com3h ago
- IHE vs. BBH: Which Healthcare ETF Is the Better Buy Right Now?Motley Fool22h ago
- Merck KGaA (XTRA:MRK) Opens New Darmstadt Testing Site As Pipeline Progress BuildsSimply Wall St.2d ago
- MRK Stock Jumps on FDA Nod for Cholesterol-Lowering PillZacks2d ago
- New Cholesterol Pill, Earnings Growth Boost Merck SharesFX Empire2d ago
- The Real Question Buried Inside Merck Stock's Premium PriceTrefis2d ago
- The First Oral Cholesterol Pill Is Here. Which of These 5 Stocks Benefits Most?24/7 Wall St.2d ago
Related
Other assets in this category.
- 8306.TMitsubishi UFJ Financial Group, Inc.3,473 USD-4.30%
- 7203.TToyota Motor Corporation2,899.5 USD-0.33%
- 9984.TSoftBank Group Corp.5,424 USD-9.01%
- 6758.TSony Group Corporation3,470 USD+0.93%
- 6861.TKeyence Corporation70,880 USD-4.28%
- NVDANVIDIA Corporation202.81 USD-2.21%
- AAPLApple Inc.333.74 USD+0.14%
- 0700.HKTencent Holdings Limited477.8 USD+3.51%
Live discussion
Sign in to join the discussion.
- No comments yet. Be the first.